Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

40.99

+0.91 (2.27%)

Oct 24, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2014 - 2019
Novel Therapeutics	1.04M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	-74.11%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2014 - 2019
United States	1.04M	Log In	Log In	Log In	Log In	Upgrade
United States and Australia	-	Log In	Log In	Log In	Log In	Upgrade
United States and Australia Growth	-	Log In	Log In	Log In	Log In	Upgrade